© 1999 American Heart Association, Inc.
Molecular Medicine |
E1A Can Provoke G1 Exit That Is Refractory to p21 and Independent of Activating Cdk2
From the Molecular Cardiology Unit (S.A., S.Z., M.A., M.D.S.), Departments of Medicine (S.A., S.Z., M.A., M.D.S.), Cell Biology (M.D.S), and Molecular Physiology & Biophysics (M.D.S), and the Graduate Program in Cardiovascular Sciences (S.Z., M.D.S.), Baylor College of Medicine, Houston, Tex.
Correspondence to Dr Michael D. Schneider, Molecular Cardiology Unit, Baylor College of Medicine, One Baylor Plaza, Room 506C, Houston, TX 77030. E-mail michaels{at}bcm.tmc.edu
Abstract—E1A can evoke G1 exit in cardiac myocytes and other cell types by displacing E2F transcription factors from tumor suppressor "pocket" proteins and by a less well-characterized p300-dependent pathway. Bypassing pocket proteins (through overexpression of E2F-1) reproduces the effect of inactivating pocket proteins (through E1A binding); however, pocket proteins associate with a number of molecular targets apart from E2F. Hence, pocket protein binding by E1A might engage mechanisms for cell cycle reentry beyond those induced by E2F-1. To test this hypothesis, we used adenoviral gene transfer to express various E2F-1 and E1A proteins in neonatal rat cardiac myocytes that are already refractory to mitogenic serum, in the absence or presence of several complementary cell cycle inhibitors—p16, p21, or dominant-negative cyclin-dependent kinase-2 (Cdk2). Rb binding by E2F-1 was neither necessary nor sufficient for G1 exit, whereas DNA binding was required; thus, exogenous E2F-1 did not merely function by competing for the Rb "pocket." E2F-1–induced G1 exit was blocked by the "universal" Cdk inhibitor p21 but not by p16, a specific inhibitor of Cdk4/6; p21 was permissive for E2F-1 induction of cyclins E and A, but prevented their stimulation of Cdk2 kinase activity. In addition, E2F-1–induced G1 exit was blocked by dominant-negative Cdk2. Forced expression of cyclin E induced endogenous Cdk2 activity but not G1 exit. Thus, E2F-1–induced Cdk2 function was necessary, although not sufficient, to trigger DNA synthesis in cardiac muscle cells. In contrast, pocket protein–binding forms of E1A induced G1 exit that was resistant to inhibition by p21, whereas G1 exit via the E1A p300 pathway was sensitive to inhibition by p21. Both E1A pathways—via pocket proteins and via p300—upregulated cyclins E and A and Cdk2 activity, consistent with a role for Cdk2 in G1 exit induced by E1A. However, p21 blocked Cdk2 kinase activity induced by both E1A pathways equally. Thus, E1A can cause G1 exit without an increase in Cdk2 activity, if the pocket protein–binding domain is intact. E1A also overrides p21 in U2OS cells, provided the pocket protein–binding domain is intact; thus, this novel function of E1A is not exclusive to cardiac muscle cells. In summary, E1A binding to pocket proteins has effects beyond those produced by E2F-1 alone and can drive S-phase entry that is resistant to p21 and independent of an increase in Cdk2 function. This suggests the potential involvement of other endogenous Rb-binding proteins or of alternative E1A targets.
Key Words: adenovirus • cell cycle • cyclin-dependent kinase • E1A • p21
This article has been cited by other articles:
 |
|
 |
|
  Y. J. Woo, C. M. Panlilio, R. K. Cheng, G. P. Liao, E. E. Suarez, P. Atluri, and H. W. Chaudhry Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2 J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ahuja, P. Sdek, and W. R. MacLellan Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration Physiol Rev, April 1, 2007; 87(2): 521 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Woo, C. M. Panlilio, R. K. Cheng, G. P. Liao, P. Atluri, V. M. Hsu, J. E. Cohen, and H. W. Chaudhry Therapeutic Delivery of Cyclin A2 Induces Myocardial Regeneration and Enhances Cardiac Function in Ischemic Heart Failure Circulation, July 4, 2006; 114(1_suppl): I-206 - I-213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ebelt, N. Hufnagel, P. Neuhaus, H. Neuhaus, P. Gajawada, A. Simm, U. Muller-Werdan, K. Werdan, and T. Braun Divergent Siblings: E2F2 and E2F4 but not E2F1 and E2F3 Induce DNA Synthesis in Cardiomyocytes Without Activation of Apoptosis Circ. Res., March 18, 2005; 96(5): 509 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hlaing, P. Spitz, K. Padmanabhan, B. Cabezas, C. S. Barker, and H. S. Bernstein E2F-1 Regulates the Expression of a Subset of Target Genes during Skeletal Myoblast Hypertrophy J. Biol. Chem., October 15, 2004; 279(42): 43625 - 43633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Oh, S. C. Wang, A. Prahash, M. Sano, C. S. Moravec, G. E. Taffet, L. H. Michael, K. A. Youker, M. L. Entman, and M. D. Schneider Telomere attrition and Chk2 activation in human heart failure PNAS, April 29, 2003; 100(9): 5378 - 5383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Diez-Juan and V. Andres Coordinate Control of Proliferation and Migration by the p27Kip1/Cyclin-Dependent Kinase/Retinoblastoma Pathway in Vascular Smooth Muscle Cells and Fibroblasts Circ. Res., March 7, 2003; 92(4): 402 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B.S. Pasumarthi and L. J. Field Cardiomyocyte Cell Cycle Regulation Circ. Res., May 31, 2002; 90(10): 1044 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oh, G. E. Taffet, K. A. Youker, M. L. Entman, P. A. Overbeek, L. H. Michael, and M. D. Schneider Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival PNAS, August 17, 2001; (2001) 191169098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minamino, V. Gaussin, F. J. DeMayo, and M. D. Schneider Inducible Gene Targeting in Postnatal Myocardium by Cardiac-Specific Expression of a Hormone-Activated Cre Fusion Protein Circ. Res., March 30, 2001; 88(6): 587 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Schneider and W. R. MacLellan Cyclin-Dependent Kinase-2 in the Birth and Death of Cardiac Muscle Cells Circ. Res., March 2, 2001; 88(4): 367 - 369. [Full Text] [PDF]
|
|
|
|
|
|
H. Oh, G. E. Taffet, K. A. Youker, M. L. Entman, P. A. Overbeek, L. H. Michael, and M. D. Schneider Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival PNAS, August 28, 2001; 98(18): 10308 - 10313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. S. Pasumarthi, S.-C. Tsai, and L. J. Field Coexpression of Mutant p53 and p193 Renders Embryonic Stem Cell-Derived Cardiomyocytes Responsive to the Growth-Promoting Activities of Adenoviral E1A Circ. Res., May 25, 2001; 88(10): 1004 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Xiao, S. Mao, G. Baumgarten, J. Serrano, M. C. Jordan, K. P. Roos, M. C. Fishbein, and W. R. MacLellan Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy and Reactivation of DNA Synthesis Circ. Res., December 7, 2001; 89(12): 1122 - 1129. [Abstract] [Full Text] [PDF]
|
|